Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Wednesday that its total revenues for the fourth quarter of 2019 rose about 23 percent, driven by continued growth in its product and services business.

For the three months ended Dec. 31, 2019, total revenues rose to $36.9 million from $30.0 million in Q4 2018, beating the average Wall Street estimate of $34.5 million and exceeding a preliminary estimate this January of $36.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.